During the past decade, UCSF Hypoxia Research Laboratory conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Hypoxia Research Laboratory" #1 collaborator was "University of California, San Francisco" with 5 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Hypoxia Research Laboratory" are "Hypoxia" (5 trials), "High Altitude" (1 trials), "Hypercapnia" (1 trials), "Hypocapnia" (1 trials) and "Oximetry" (1 trials). Many other conditions were trialed in "UCSF Hypoxia Research Laboratory" in a lesser frequency.

Most popular intervention types in "UCSF Hypoxia Research Laboratory" are "Device" (6 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pulse oximeter" (3 trials), "Ibuprofen" (1 trials), "Oximeter" (1 trials), "Spry Loop Band" (1 trials) and "Spry Loop oximeter" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Hypoxia Research Laboratory" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Hypoxia Research Laboratory". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UCSF Hypoxia Research Laboratory, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Hypoxia Research Laboratory, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".